X-5903545-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000381095.8(NLGN4X):āc.1133A>Gā(p.Lys378Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00029 in 1,208,306 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 117 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
ENST00000381095.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLGN4X | NM_181332.3 | c.1133A>G | p.Lys378Arg | missense_variant | 5/6 | ENST00000381095.8 | NP_851849.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLGN4X | ENST00000381095.8 | c.1133A>G | p.Lys378Arg | missense_variant | 5/6 | 1 | NM_181332.3 | ENSP00000370485 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000281 AC: 31AN: 110346Hom.: 0 Cov.: 22 AF XY: 0.000246 AC XY: 8AN XY: 32544
GnomAD3 exomes AF: 0.000296 AC: 53AN: 178855Hom.: 0 AF XY: 0.000327 AC XY: 21AN XY: 64183
GnomAD4 exome AF: 0.000291 AC: 320AN: 1097909Hom.: 0 Cov.: 32 AF XY: 0.000300 AC XY: 109AN XY: 363297
GnomAD4 genome AF: 0.000281 AC: 31AN: 110397Hom.: 0 Cov.: 22 AF XY: 0.000245 AC XY: 8AN XY: 32605
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 28, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | NLGN4X: BS2 - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 20, 2022 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at